4 minutes read time.
Clinical Decision Solutions (CDS) offer technology-enabled support to address these hurdles. Integrated with Electronic Health Records (EHRs) and prescribing systems, CDS platforms provide clinicians with real-time, patient-specific recommendations that reduce risk and support clinical excellence.
Challenges in Medication Management
1. Fragmentation of Information Systems
Disjointed information systems make it difficult for clinicians to access a complete view of a patient’s medication history. This issue is particularly problematic during care transitions, such as hospital discharge or referral between departments. Fragmented records can result in duplication, omission, or inappropriate continuation of therapy [1].
CDS helps bridge these data gaps by aggregating and displaying up-to-date medication records from multiple sources. A unified view enhances decision-making, minimises prescribing errors, and supports continuity of care.
2. Polypharmacy and Drug Interactions
Polypharmacy—the simultaneous use of multiple medications—is especially common among elderly patients and those with chronic conditions. However, it significantly increases the risk of drug–drug interactions and adverse events [2].
CDS platforms analyse entire medication profiles to detect unsafe combinations, duplications, and contraindications. Automated alerts guide prescribers in selecting safer alternatives, avoiding high-risk drugs, and tailoring treatment based on patient-specific factors like renal function [3].
3. Adherence Issues
Non-adherence remains a persistent barrier to treatment success. Contributing factors include complicated dosing schedules, side effects, and a lack of patient understanding. This non-adherence is estimated to result in significant clinical and financial consequences across a wide range of diseases [4].
CDS can support adherence by generating simplified medication plans, automated reminders, and patient education tools. By empowering patients with the knowledge and tools to follow their treatment correctly, CDS improve both safety and outcomes.
4. Inadequate Deprescribing Guidelines
Many medications are continued unnecessarily due to the absence of clear deprescribing protocols. This can lead to prolonged use, side effects, and increased healthcare costs. The lack of clinician support in tapering or stopping medications has been identified as a key contributor to inappropriate prescribing [5].
CDS solutions help clinicians identify potentially inappropriate medications and offer evidence-based recommendations for tapering or discontinuation. These insights promote safer prescribing behaviours and reduce polypharmacy-related risks.
Why Choose MIMS Integrated for Your Clinical Decision Solutions?
MIMS Integrated is a leading Clinical Decision Solutions platform tailored to healthcare systems across Asia-Pacific. Designed to enhance safety and efficiency, it offers:
- Comprehensive drug safety checks including interactions, duplications, contraindications, and dosing alerts
- Local formulary adaptation
- Patient-centred tools for adherence support and education
Seamlessly integrated into existing EHR and CPOE systems, MIMS Integrated enables clinicians to make safer, more informed decisions—while empowering patients with better care continuity. To support true interoperability—the ability of different healthcare systems to exchange and understand shared data—it leverages standardised medication lists aligned with international standards, including the Australian Medicines Terminology (AMT), New Zealand Medicines Terminology (NZMT), Malaysia Drug Code (MDC) and Singapore Drug Dictionary (SDD), . This ensures consistent medication data across systems and providers, helping reduce errors and enabling more coordinated, patient-centered care.
At every step of the medication journey—from prescribing to deprescribing—MIMS Integrated empowers healthcare teams with evidence-based tools for safer, smarter clinical decisions.
✅ Real-time medication safety alerts
✅ Tailored to your hospital’s formulary and local needs
✅ Supports patient engagement and continuity of care
✅ Scalable across departments, hospitals, and health systems
Studies have shown that CDS tools like MIMS Integrated can significantly reduce unnecessary lab testing and pharmacy-related costs, supporting measurable operational improvement [6][7].
Contact us today – Discover how MIMS Integrated can help your organisation reduce medication errors, optimise therapy, and support patient-centred care!
REFERENCES
- Tariq, R.A., Vashisht, R., Scherbak, Y. Medication Dispensing Errors and Prevention. StatPearls, 2024. See more.
- Maher, R.L., Hanlon, J.T., Hajjar, E.R. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014.
- Zed, P.J., et al. Drug-related visits to the emergency department. CJEM. 2008.
- Cutler, R.L., et al. Economic impact of medication non-adherence by disease groups: A systematic review. BMJ Open. 2018.
- Reeve, E., et al. Review of deprescribing processes and potential recommendations. JAMA Intern Med. 2015.
- Calloway, S., Akilo, H., Bierman, K. Impact of CDS on pharmacy costs. Hosp Pharm. 2013.
- Algaze, C.A., et al. CDS reduces unnecessary lab testing. Pediatrics. 2016.
